Biora Therapeutics Inc expected to post a loss of $1.60 a share - Earnings Preview

Biora Therapeutics

12/08/2023 03:05

* Biora Therapeutics Inc  BIOR.OQ   BIOR.O  is expected
to show a
fall in quarterly revenue when it reports  results on August
14. 
    * The San Diego California-based  company is expected to
report  a
80.8% decrease in revenue to $20 thousand from $104 thousand a
year ago, according to the estimate from one analyst, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Biora Therapeutics
Inc is
for a loss of $1.60 per share. 
    * The one available analyst rating on the shares is "buy".  
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "Buy".​
    * Wall Street's median 12-month price target for Biora
Therapeutics Inc is $82.5​, above​ its last closing price
of $3.46. ​​​

This summary was machine generated August 12 at 02:04 GMT.  All
figures in US dollars  unless otherwise stated